Atrys Health, S.A. (BME:ATRY)

Market Cap	224.59M -16.9%
Revenue (ttm)	226.24M +7.2%
Net Income	-24.59M
EPS	-0.32
Shares Out	75.87M
PE Ratio	n/a
Forward PE	32.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,968
Average Volume	48,790
Open	2.970
Previous Close	3.020
Day's Range	2.950 - 3.020
52-Week Range	2.480 - 3.590
Beta	0.61
RSI	45.92
Earnings Date	Mar 27, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,016
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.